Evidence map›Paper›PMID 39215540›Full record

ArticleGlia2024

Loss of prohibitin 2 in Schwann cells dysregulates key transcription factors controlling developmental myelination.

Emma R Wilson, Gustavo Della-Flora Nunes, Shichen Shen, Seth Moore, Joseph Gawron, Jessica Maxwell, Umair Syed, Edward Hurley, Meghana Lanka, Jun Qu and 4 more

Abstract read
In one paragraph

Article in Glia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Emma R WilsonDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.ORCID 0000-0002-8069-0173
Gustavo Della-Flora NunesDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.ORCID 0000-0001-9323-3556
Shichen ShenDepartment of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Seth MooreDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.ORCID 0000-0001-9488-3905
Joseph GawronDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Jessica MaxwellDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Umair SyedDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Edward HurleyDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Meghana LankaDepartment of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Jun QuDepartment of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Laurent DésaubryCenter of Research in Biomedicine of Strasbourg, Regenerative Nanomedicine (UMR 1260), INSERM, University of Strasbourg, Strasbourg, France.
Lawrence WrabetzDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Yannick PoitelonDepartment of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, New York, USA.ORCID 0000-0001-9868-1569
M Laura FeltriDepartment of Biochemistry, Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.

Funding

Laminin Receptors and Signals in Schwann CellsR01NS045630 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SIM, FRASER JAMES · 2003 to 2024
$5.9M
Transduction of Mechanical Stimuli in Myelination and Peripheral Nerve RepairR01NS110627 · NINDS · ALBANY MEDICAL COLLEGE · PI POITELON, YANNICK · 2020 to 2024
$2.1M
The prohibitin family and their function in myelination and axonal healthR01NS100464 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI FELTRI, M. LAURA · 2016 to 2020
$1.7M
YAP/TAZ in Schwann Cells as Potential Therapeutic Targets in CMT1A and HNPP.F30NS125928 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MOORE, SETH MICHAEL · 2022 to 2023
$66k
NINDS NIH HHS F30 NS125928NINDS NIH HHS NIH-NINDS-F30NS125928NINDS NIH HHS NIH-NINDS-R01NS100464NINDS NIH HHS NIH-NINDS-R01NS110627NINDS NIH HHS R01 NS045630NINDS NIH HHS R01 NS100464NINDS NIH HHS R01 NS110627
6 · The paper itself

Abstract

Schwann cells are critical for the proper development and function of the peripheral nervous system (PNS), where they form a collaborative relationship with axons. Past studies highlighted that a pair of proteins called the prohibitins play major roles in Schwann cell biology. Prohibitins are ubiquitously expressed and versatile proteins. We have previously shown that while prohibitins play a crucial role in Schwann cell mitochondria for long-term myelin maintenance and axon health, they may also be present at the Schwann cell-axon interface during development. Here, we expand on this, showing that drug-mediated modulation of prohibitins in vitro disrupts myelination and confirming that Schwann cell-specific ablation of prohibitin 2 (Phb2) in vivo results in severe defects in radial sorting and myelination. We show in vivo that Phb2-null Schwann cells cannot effectively proliferate and the transcription factors EGR2 (KROX20), POU3F1 (OCT6), and POU3F2 (BRN2), necessary for proper Schwann cell maturation, are dysregulated. Schwann cell-specific deletion of Jun, a transcription factor associated with negative regulation of myelination, confers partial rescue of the developmental defect seen in mice lacking Schwann cell Phb2. Finally, we identify a pool of candidate PHB2 interactors that change their interaction with PHB2 depending on neuronal signals, and thus are potential mediators of PHB2-associated developmental defects. This work develops our understanding of Schwann cell biology, revealing that Phb2 may modulate the timely expression of transcription factors necessary for proper PNS development, and proposing candidates that may play a role in PHB2-mediated integration of axon signals in the Schwann cell.

Indexed as

Myelin SheathProhibitinsRepressor ProteinsSchwann CellsAnimalsCells, CulturedMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicTranscription FactorsPhb2 protein, mouseProhibitinsRepressor ProteinsTranscription FactorsBAP32BAP37BRN2c‐JUNKROX20OCT6REA

Identifiers

PMID39215540
PMCPMC11577967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.